X

Month: August 2019

Intercept Pharmaceuticals beats in Q2, keeps full-year outlook unchanged

Intercept Pharmaceuticals (NASDAQ: ICPT) on Wednesday reported second-quarter results that surpassed Wall Street expectations, riding on the strong growth of…

Ionis Pharmaceuticals stock surges on Q2 earnings beat

Ionis Pharmaceuticals (NASDAQ: IONS) reported better-than-expected second quarter results pushing the stock above 3% in the pre-market trading hours. The…

CyberArk Q2 profit beats estimates, chief revenue officer to resign

CyberArk Software Ltd. (NASDAQ: CYBR) reported a 60% jump in earnings for the second quarter of 2019 as a 27%…

Teva’s Q2 results beat market expectations

Teva Pharmaceutical Industries (NYSE: TEVA) topped revenue and earnings estimates for the second quarter of 2019, giving shares a lift…

Papa John’s Q2 profit drops 25%, misses estimates

Papa John’s International (NASDAQ: PZZA) reported a 25% plunge in earnings for the second quarter due to negative comps for…

HubSpot beats Q2 views; stock gains on strong FY19 outlook

HubSpot’s (NYSE: HUBS) second quarter 2019 earnings and revenue beat consensus estimates. The company also lifted its earnings and revenue…

Wynn Resorts Q2 earnings in line with estimates

Wynn Resorts (NASDAQ: WYNN) stock surged above 4% after the bell after the casino operator reported better-than-expected second quarter results.…

LendingClub posts narrower-than-expected loss in Q2

LendingClub Corporation (NYSE: LC) reported a narrower loss in the second quarter helped by improving customer acquisition and origination and…

Match Group stock soars as the market falls in love with Q2 results

Match Group Inc. (Nasdaq: MTCH) reported better-than-expected revenues and profit for the second quarter of 2019, aided mainly by a further strong…

GW Pharmaceuticals beats revenue estimates in Q2

GW Pharmaceuticals (NASDAQ: GWPH)topped revenue estimates for the second quarter of 2019, sending the stock climbing over 11% during aftermarket…